Steve E. Krognes
2016
In 2016, Steve E. Krognes earned a total compensation of $823.8K as Chief Financial Officer and Treasurer at Denali Therapeutics.
Compensation breakdown
| Bonus | $398,750 |
|---|---|
| Salary | $425,000 |
| Total | $823,750 |
Krognes received $425K in salary, accounting for 52% of the total pay in 2016.
Krognes also received $398.8K in bonus.
Rankings
In 2016, Steve E. Krognes' compensation ranked 9,167th out of 14,075 executives tracked by ExecPay. In other words, Krognes earned more than 34.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,167 out of 14,075 | 35th |
Division Manufacturing | 3,544 out of 5,489 | 35th |
Major group Chemicals And Allied Products | 1,222 out of 1,895 | 36th |
Industry group Drugs | 969 out of 1,538 | 37th |
Industry Biological Products, Except Diagnostic Substances | 165 out of 279 | 41st |
Source: SEC filing on April 26, 2018.
Krognes' colleagues
We found three more compensation records of executives who worked with Steve E. Krognes at Denali Therapeutics in 2016.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019